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Abstract
Many species of streptococci secrete and use a competence-stimulating peptide (CSP) to initiate quorum
sensing for induction of genetic competence, bacteriocin production, and other activities. These signaling
molecules are small, unmodified peptides that induce powerful strain-specific activity at nano-molar con-
centrations. This feature has provided an excellent opportunity to explore their structure–function rela-
tionships. However, CSP variants have also been identified in many species, and each specifically
activates its cognate receptor. How such minor changes dramatically affect the specificity of these peptides
remains unclear. Structure–activity analysis of these peptides may provide clues for understanding the
specificity of signaling peptide–receptor interactions. Here, we use the Streptococcus mutans CSP as an ex-
ample to describe methods of analyzing its structure–activity relationship. The methods described here
may provide a platform for studying quorum-sensing signaling peptides of other naturally transformable
streptococci.
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nuclear magnetic resonance spectroscopy, Streptococcus mutans.
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TOCSY Total correlation spectroscopy
NOESY Nuclear Overhauser effect spectroscopy
DOSY Diffusion-ordered spectroscopy
SDS Sodium dodecyl sulfate
ONPG O-Nitrophenyl-D-galactopyranoside
1. Introduction
Naturalgenetictransformationisaprocessbywhichbacteriaareable
to take up and integrate exogenous free DNA from their environ-
ment (1, 2). This process enables the recipient organisms to acquire
novel genes, thereby promoting the emergence of antibiotic resis-
tance, genetic variation, and rapid evolution of virulence factors
(1–4). Many members of the genus Streptococcus are naturally trans-
formable and each depends on a signaling peptide-mediated quo-
rum-sensing system for induction of genetic competence (3–5).
Activation of quorumsensing for genetic competence and other co-
ordinatedactivitiesinthesespeciesrequiresatleastsixgeneproducts
encoded by comCDE, comAB,a n dcomX (Fig. 1). The comC gene
encodes a competence-stimulating peptide (CSP) precursor, which
is cleaved and exported through a peptide-specific ABC transporter
encoded by comAB, releasing CSP into a extracellular environment
(2–6). The comDE encodesa two-componentsystem consistingofa
histidine kinase sensor protein (ComD) and its cognate response
regulator (ComE) that specifically senses and responds to CSP. At
a critical concentration, the CSP activates autophosphorylation of
the ComD of neighboring cells. The phosphate group is then trans-
ferred to the ComE, which in turn activates its target genes, includ-
ing comX that encodes a competence-specific sigma factor
recognizing a consensus sequence (com-box) at the promoter
regions of late competence genes, triggering the signaling cascade
for genetic competence(2–5). Thequorum-sensingsystem in Strep-
tococcusmutansrepresentsauniqueregulatorymechanism,sincethis
system regulates both bacteriocin production and genetic compe-
tence (2, 6, 7). In contrast to S. mutans, Streptococcus pneumoniae
requires two separate signaling systems, the ComCDE and BlpRH,
to regulate genetic competence and bacteriocin production (8).
Many CSPs from naturally transformable streptococci have
been identified and their activity for genetic competence has been
validated (2–4). These signaling molecules are small, unmodified
peptides, ranging from 14 to 25 residues in length, and induce
208 X. Tian et al.powerful strain-specific activity at nano-molar concentrations.
Some CSPs have been chemically synthesized and used as a tool
to induce genetic competence during molecular cloning. Recent-
ly, the structure–activity relationships of CSPs from both S. pneu-
moniae and S. mutans have been analyzed (9, 10). The CSPs from
these organisms have been found to adopt an amphipathic, α-he-
lical conformation with a defined hydrophobic face that contrib-
utes to the CSP specificity. Furthermore, the CSP from S.
mutans reveals two functional domains (10). The C-terminal
structural motif consisting of a sequence of polar hydrophobic
charged residues is crucial for activating the signal transduction
pathway, while the core α-helical structure extending from residue
5 through to the end of the peptide is required for receptor bind-
ing. Sequence alignment of CSPs from various streptococci shows
that almost all CSPs have such a motif at the C-termini (10), sug-
gesting that these CSPs likely have similar functional domains.
However, CSP variants have been identified in many species
and each induces competence in a highly strain-specific manner.
Thus, the CSP variants may provide an excellent model to
study peptide–receptor interactions in these bacteria. Here, we
extend our technical information and describe methods and
protocols for structure–activity analysis of CSP from S. mutans
Fig. 1. Aschematicdiagramdescribingthequorum-sensingsystemanditscontrolledcooperativeac-
tivities in Streptococcus mutans. The signaling peptide or CSP induces quorum-sensing cascade when
reaching to a critical concentration. This in turn activates the production of numerous bacteriocins
and genetic competence, resulting in killing of other species, DNA release, and gene exchange.
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(NMR)andcirculardichroism(CD)spectroscopies(seeAppendix).
The methods described herein may provide a platform and ra-
tionale for analyzing CSPs from other naturally transformable
streptococci.
2. Materials
and Methods
2.1. Chemical
Synthesis of Signaling
Peptides
Efficient structural characterization of signaling peptides by CD
and NMR requires purified (≥95% purity) and soluble peptides.
In our study, all the peptides were commercially synthesized and
purified by reversed-phase high-pressure liquid chromatography.
Their identity was confirmed by a mass spectrometry (10). The
peptides were lyophilized and stored at –20°C until use. For CD
andNMRstudies,eachpeptidewasdissolvedinanappropriatesol-
vent. Foractivity assays,each peptidewasfreshlydissolvedin sterile
distilledwaterataconcentrationof1.0mM(stocksolution),which
was further diluted as required.
2.2. Sample
Preparation
The first step was to optimize sample conditions by adjusting pH,
ionic strength, and temperature to mimic physiological conditions
withtheconstraintinwhichtheconditionswerecompatiblewithda-
ta acquisition (11). For CD spectroscopy, peptide concentrations
were typically on the order of 50µM with 200µL of solution (12).
Buffers, co-solvents, and additives (e.g., detergent molecules) were
non-chiral, sodium-free, and non-absorbing within the wavelength
range (typically 250–180 nm). For NMR studies, buffers,
co-solvents, and additives were hydrogen-free or deuterated.
Samples could be dissolved in as little as 10µL, but typically,
spectrometers were designed for sample volumes of at least
500µL. Due to the inherently low sensitivity, concentrations
of peptides ranged from 1.0 to 10 mM (13).
In our study, synthetic peptides CSP (UA159sp) and
TPC3 for CD and NMR were dissolved in 95/5/0%, 70/
0/30%, 30/0/70%, or 0/0/100% aqueous buffer/D2O/
TFE-d2, or 95/5 aqueous buffer/D2Ow i t h3 0 0m MD P C -
d38 (98 atom %D), where TFE refers to trifluoroethanol and
DPC-d38 refers to perdeuterated dodecylphosphocholine (10,
13). The aqueous buffer used for sample preparation con-
tained 50 mM K2HPO4/KH2PO4 at pH7.0. The concentra-
tion of peptides for solutions containing 100% TFE-d2 or
DPC-d38 was 2 and 5 mM. For diffusion studies, we analyzed
the solutions containing peptides and DPC-d38 by lyophilizing
210 X. Tian et al.and dissolving them in an equivalent volume of D2O (99.9
atom %D) followed by transferring into a 5 mm OD, D2O
magnetic susceptibility-matched NMR tube (BMS-3; Shigemi,
Tokyo). The sample height of 1.2 cm ensured that the entire
sample was within the radio frequency coils, which was essen-
tial for artifact-free and accurate diffusion measurements.
2.3. CD Spectroscopy CD spectra for peptides and reference solutions were recorded at
298 K on a Jasco J-920 CD spectrometer with a 1-mm quartz cu-
vette. Spectra were collected and averaged over 16 scans from
wavelengths 190 to 250 nm with a 0.1-nm step resolution. CD
measurements were performed and analyzed to confirm the
effects of TFE on the secondary structure of the peptides (14,
15). In our study, we analyzed the peptides by using CD analysis
package DICHROWEB (www.cryst.bbk.ac.uk/cdweb/html)
(16).
2.4. NMR
Spectroscopy
Initial experiments in our study included
1H-
1H COSY (correla-
tion spectroscopy) and
1H-
1H TOCSY (total correlation spectros-
copy). The COSY spectra were used to correlate
1H atoms that
were ≤3 bonds apart, and to determine the
3JH
N
H
α coupling val-
ues between H
N and H
α, whereas the TOCSY spectra were used
to correlate all
1H atoms within a spin system that were ≤3 bonds
apart (17). In addition, 1D and 2D
1H NMR data sets of the pep-
tides were collected on a Bruker AVANCE 500 spectrometer.
Unless otherwise stated,
1H detected spectra were acquired at a
repetition rate of 1.5 s
−1 at 293 K with water frequency centered
on carrier frequency. For structural determination, phase-sensitive
2D
1H-
1H NOESY,
1H-
1H COSY, and
1H-
1H TOCSY data sets
(MLEV17) were recorded at 293 K with a presaturation or with a
3–9–19 pulse sequence for water suppression.
1H detected 2D
DOSY data sets were recorded using a stimulated-echo sequence
with bipolar-gradient pulses and 32 t1 blocks of 64 transients
each. NMR data sets were processed using Bruker XwinNMR 3.5.
2.5. Structural
Determination
Structural determination of the peptides followed the procedures
as described previously (10). Briefly, spin systems (i.e., amino acid
residues) were identified through chemical shifts and TOCSY
cross-peak patterns. Distance constraints determined from inte-
gration of the 250-ms NOESY spectra were classified into four
groups: strong, medium, weak, and very weak corresponding to
interproton distance ranges of G2.3, 2.0–3.5, 3.3–5.0, and 4.8–
6.0Å, respectively. The
3JH
N
H
α coupling values determined from
COSY spectra were averaged over a distribution of dihedral
angles. Assessment of hydrogen bonding was carried out on the
basis of H
α
i–H
N
i+3, and H
α
i–H
N
i+4 observed NOESY connectiv-
ities, dihedral angles, and chemical shift index values. For residues
involved in hydrogen bonding, hydrogen bonds between COi
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N
i+4 were included as constraints by restraining rH–O to
1.2–1.9Å and rN–O to 1.8–2.9Å.
From the NMR-derived structural constraints, two series of
structural calculations were performed with or without added hy-
drogen bonds to assess the effect of adding suspected hydrogen
bondsintothestructurecalculation.Allstructuralcalculationswere
based on previous studies using the XPLOR 3.1 software package
(10).Finalcalculatedstructureswereenergyminimizedwith2,000
conjugategradientstepsbeforeprocessingtotherestrainedanneal-
ing molecular dynamics calculation. A total of 33 and 21 UA159sp
and 43 and 36 TPC3 (with and without hydrogen bonds included
within the simulation) lowest energy structures were retained that
had no violations of NOESY constraints >0.5Å (18). The overall
quality of these refined structures was examined with the program
PROCHECK (19). Except for random coil sections, all backbone
dihedral angles resided in the well-defined, acceptable regions of
the Ramachandran plot. Three-dimensional structures of
UA159sp and TCP3 determined from NMR were constructed
by computer simulation using the VMD software (http://www.
ks.uiuc.edu/Development).
2.6. Construction
of comC Mutant
That Was Defective
in Producing CSP
To assay quorum sensing (QS) activation in response to addition
of a peptide without interference by endogenous CSP from a
wild-type strain, a comC mutant that was unable to produce,
but still responded to CSP was constructed in S. mutans GS5 us-
ing the strategy as described previously (20). Following genetic
recombination via allelic exchange, the comC deletion mutant
was created by insertion of a spectinomycin (Spec
r) resistance cas-
sette (21) into the comC gene of strain GS5. The mutant was
then confirmed by polymerase chain reaction (PCR) and se-
quencing of the junction site of the Spec cassette as described
previously (20). The resulting mutant was named SMdC and
was used as a negative background strain of signaling peptide
(CSP) for CSP-dependent assays of genetic competence, lacZ
reporter, and bacteriocin production.
2.7. Construction of
lacZ Transcriptional
Reporter Strains
To assay QS activation in response to addition of a peptide, we
constructed two types of lacZ transcriptional reporter strains that
represented two levels of QS-activated gene expression. The first
was a lacZ reporter gene fused to the comDE promoter, which
allowed monitoring of the activity of the comDE promoter in re-
sponse to a test peptide. The second strain was a lacZ reporter
gene fused to the promoter of nlmAB, the gene encoding a non-
lantibiotic bacteriocin and its expression directly controlled by the
ComE (6, 22). This strain allowed assay of comDE-controlled bac-
teriocin production.
For the first reporter strain, we simply transformed previously
constructed vector pYH2 (10) into the comC mutant (SMdC) to
212 X. Tian et al.generate SMdC-pYH2 (PcomDE::lacZ, comC
−,S p e c
r,K a n
r).
pYH2 was constructed in such a way that the comDE promoter
was fused to a promoterless lacZ gene on the backbone of
Streptococcus–Escherichia coli shuttle vector pSL. The vector
pSL was also transformed into the same mutant SMdC and
used as a background control (SMdC-pSL). These strains were
then assessed for lacZ reporter activity in response to addition
of peptides.
For the second reporter strain, we generated a chromosomal
nlmAB–lacZ fusion strain by transforming a PnlmAB::lacZ fusion
construct pOMZ47 (6) into both comC mutant SMdC and wild-
type GS5. The resulting reporter strains were confirmed by PCR
and sequencing of the fusion sites as described previously (6). The
confirmed reporter strains were respectively named SMdC-PnlmAB
(PnlmAB::lacZ, comC
−,K a n
r,S p e c
r)a n dS M G S 5 - P n l m A B
(PnlmAB::lacZ,K a n
r). The strain SMGS5-PnlmAB was used a pos-
itive control.
2.8. CSP-Dependent
Transformation Assay
To determine if synthetic peptides activated quorum sensing for
induction of genetic competence, we used the comC deletion mu-
tant that was unable to produce, but still responded to CSP, to
assay peptide-dependent genetic transformation using the method
as described previously (2, 10). A streptococcal suicide vector
pVA-gtfA, which harbored a 2.4-kb fragment of the S. mutans
gtfA gene and an erythromycin resistance marker, was used as
transforming DNA. The wild-type GS5 was used as a positive
control, while both ComC (SMdC) and ComE mutants (SMdE)
were used as negative controls. The wild-type strain was grown on
Todd–Hewitt yeast extract (THYE) medium, whereas the
mutants were maintained on THYE plus spectinomycin. When
culture reached to early mid-log phase (OD600≈0.25), an aliquot
of CSP was added into the culture at a final concentration of
50 nM (AC50≈0.25 nM). After 20 min of incubation at 37°C,
an aliquot of transforming DNA of plasmid pVA-gtfA confer-
ring erythromycin resistance was added at a final concentration
of 1µg mL
−1. The culture was incubated for additional 2 h before
platedonTHYEagarplatesplus10µgmL
−1erythromycin.Priorto
addition of transforming DNA, an aliquot of the cell suspension
was plated on THYE plates containing the same antibiotic to mon-
itor spontaneous mutation. Transformation frequency was
expressed as percentage of transformants against total viable recip-
ient cells per milliliter cell suspension.
2.9. β-Galactosidase
Activity Assay
A lacZ reporter assay was performed to monitor quorum-sensing
activation using the same method as described previously (10).
The newly constructed lacZ reporter strains were used to assay
and quantify β-galactosidase activity in response to test pepti-
des. Aliquots of samples were taken to prepare cell lysates at
Structure–Activity Analysis of QS Signaling Peptides 213different time points T0, T15, T30, T60, and T120 after addition
of a test peptide. Protein concentrations of the supernatants
were determined by Bio-Rad protein assay (Bio-Rad). Specific
β-gal activities (A420 min
−1 mL
−1 mg
−1 protein) were calculated
from triplicate samples from two independent experiments. The
data from the β-gal activity experiments were then normalized
against negative or background controls and plotted as percen-
tages of maximal activation versus log peptide concentrations.
The half maximal activation concentration (AC50)w a sd e t e r -
mined from the sigmoidal dose–response curve using Prism 4
(Graphpad, San Diego, CA, USA).
2.10. Assay
for QS-Controlled
Bacteriocin Production
The S. mutans comC mutant SMdC as well as its parent GS5 and
wild-type strain UA159 (positive controls) were used to assay for
bacteriocin production using a modified agar plate method (7,
23–25). Briefly, an aliquot of mid-log phase cells of the S. mutans
wild-type strains and mutant SMdC grown under a condition
with or without use of CSP or a test peptide were stabbed onto
THYE agar plates. The plates were incubated anaerobically at
37°C for 6 h before carefully overlaid with 100µL of cell suspen-
sion (about 10
6CFU/mL
−1) of an indicator strain Streptococcus
sanguinis SK108. The plates were further incubated anaerobically
at 37°C for 24 h before inspection of bacteriocin production. The
S. mutans strains showing an inhibitory zone around the stabs
were scored as positive for bacteriocin production. The plates
were then photographed for records.
3. Results
and Discussion
3.1. CD and NMR
Structural Analyses
of the Signaling
Peptides
CD and NMR spectroscopy are non-destructive and non-invasive
techniques that have been widely used to determine secondary
folding features of proteins or peptides (14–17). In addition,
NMR spectroscopy records data from “spin-active” nuclei, such
as
1H,
13C,
15N, or
31P. These nuclei are sensitive to their chem-
ical environment, which is determined by the type and number of
bonds and the position and proximity of other chemical entities
and the solvent. Thus, NMR is a powerful tool that can be used
to determine atomic level structural information, dynamics
(chemical exchange, motional fluctuations, proton exchange), li-
gandbinding,multimericstates,andeffectsofcompetitivereceptors
(11, 15, 26).
Using CD and NMR spectroscopy, we have determined the
three-dimensional structures of two signaling peptides, UA159sp
214 X. Tian et al.from S. mutans UA159 and a C-terminally truncated peptide
TPC3 from JH1005 defective in genetic competence (10). Initial
NMR data for both peptides were recorded in aqueous buffer to
provide an assessment of the structural nature of the peptides. In
the presence of water, both peptides were not soluble enough for
extensive NMR studies. In TFE, however, these peptides formed
well-defined α-helices from residues Leu4-Gly20 of UA159sp and
Ser5-Thr16 of TPC3 (Fig. 2). Both UA159sp and TPC3 formed
a similar structure in TFE and DPC-d38 micelles, although the C-
terminal three residues of TCP3 were truncated. The structural
coordinates for two peptides have been deposited in the RCSB
Protein Data Bank (http://www.pdb.org/) with RCSB ID code
rcsb039055 or PDB ID code 2I2J for UA159sp and RCSB ID
code rcsb039053 or PDB ID code 212H for TPC3.
Fig. 2. Computer-simulated three-dimensional structures of UA159sp and TPC3 determined by NMR
and CD analyses. Only the α-helical portions of the peptides with designated hydrophobic and hydro-
philic residues are presented. a A comparison in three-dimensional structures between UA159sp
(CSP) and TPC3 that lacked the proposed C-terminal motif. b UA159sp viewed from different angles
indicates the positions of phenylalanine (F) residues on the core of α-helix and C-terminal motif of
slightly motional freedom.
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that both UA159sp and TPC3 formed amphipathic α-helices with
a well-defined hydrophobic face characterized by a row of four
highly hydrophobic phenylalanines (F7, F8, F11, and F15) on
one side and hydrophilic residues on another side (Fig. 2). The
hydrophobic face comprised about 40% of the surface of the helix,
whereas hydrophilic and charged residues comprised the remain-
der of the surface. A major structural difference between
UA159sp and TPC3 was that UA159sp showed a clear C-terminal
motif of slightly more motional freedom than TPC3. From struc-
turesofothersimilarbindingpeptides,awell-definedrowofhydro-
phobic residues on an amphipathic α-helix is common and
necessary for ligand binding to the receptor protein (12, 19). Our
work suggests that the quorum-sensing signaling peptides
from S. mutans, probably from other naturally transformable
streptococci, fall into the FXXFF motif family, a general pro-
tein–protein interaction motif, where the interaction is made
through a hydrophobic face formed by the hydrophobic resi-
dues packed into a hydrophobic pocket of the receptor (11,
12, 26). The fact that the amphipathic helical structure is
reflected in the binding and induction of quorum-sensing sug-
gests that the peptide may be helical within the active site of
the receptor. The membrane environment may help to form
the helical structure, facilitating binding to the receptor. We
have chosen to dissolve the peptides in widely used solvent
TFE because it improves structural stability of peptides and is
considered to be biologically relevant (27). TFE is also thought
to mimic a protein receptor environment by stabilizing helices in
regions with intrinsic α-helical propensity that are likely to form
helices when binding to their protein partner.
3.2. Signaling
Peptide–Receptor
Activation in Newly
Constructed Strains
In previous studies, we exclusively used S. mutans UA159 and its
derivatives to assay QS activation in response to signaling peptides
(2, 10). However, this genome sequence reference strain is not a
typical producer for CSP-induced bacteriocins (7, 24, 25). To
construct a comC mutant that allowed us to assay CSP-dependent
bacteoricin production, we transformed the previously generated
comC deletion construct (20)i n t oS. mutans GS5, a wild-type
strain that was demonstrated to produce all known QS-controlled
bacteriocins (6, 7, 22). The new mutant, named SMdC, was con-
firmed to have the internal region of comC replaced by a spectino-
mycin (Spec
r) resistance cassette. The mutant was confirmed to be
defective in quorum sensing for induction of genetic competence
(Fig. 3) and bacteriocin production (Fig. 4), unless CSP or a pep-
tide agonist was added into the culture. Our work confirmed that
this mutant provided an excellent negative background, enabling
the assay of peptide-dependent QS activation without interference
by endogenous CSP.
216 X. Tian et al.We also used this mutant (SMdC) as a host to generate two
types of lacZ transcriptional reporter fusion strains to assay the
promoter activity of QS-controlled target genes, comDE and
nlmAB, in response to addition of CSP. The lacZ reporter strain,
SMdC-pYH2 (PcomDE::lacZ, comC
−, Spec
r, Kan
r), along with its
background control strain SMdC-pSL (comC
−, Spec
r, Kan
r) were
then assayed for β-galactosidase activity. The results confirmed
that upon addition of CSP strain SMdC-pYH2 was induced to ex-
press predicted β-gal activity at similar levels to those of the pre-
viously constructed lacZ reporter strain in UA159 (10). In
contrast, the background control strain SMdC-pSL did not show
significant difference in the expression of β-gal activity. To assay
QS activation of the downstream genes controlled by the
ComCDE signaling transduction pathway, we also constructed
two nlmAB–lacZ fusion strains by transforming a previously gen-
erated fusion construct PnlmAB::lacZ (6)i n t oS M d C - G S 5a n d
parent GS5. These strains were genetically confirmed and named
SMdC-PnlmAB (PnlmAB::lacZ, comC
−,K a n
r,S p e c
r)a n d
SMGS5-PnlmAB (PnlmAB::lacZ,K a n
r), respectively. The β-gal
activity assay showed that prior to addition of CSP SMdC-
PnlmAB was defective in expressing a normal level of β-gal activity
(Fig. 4a). Upon addition of CSP, however, SMdC-PnlmAB was
rapidly induced to express an increasing level of β-gal activity
and reached to the highest level around 90 min after addition
of CSP (Fig. 4b). Interestingly, SMdC-PnlmAB still maintained
such a high level of the activity for at least 2 h. Clearly, such
expression of β-gal activity appeared to be a major difference
betweenthisreporterstrainandSMdC-pYH2,inwhichtheexpres-
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Fig. 3. Induction of genetic competence of the comC mutant (SMdC) in response to addition of CSP. S.
mutans wild-type GS5 was used as a positive control, while the comE deletion mutant (SMdE) was used
as a negative control.
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CSP (10). However, the expression of β-gal activity by SMdC-
PnlmAB was highly inconsistent with those of other reports (6,
7), suggesting that the expression of nlmAB gene was likely en-
hanced by an unknown factor following initial activation by CSP.
Thus, both lacZ reporter strains representing two levels of gene
regulation provided us with a sensitive detecting system to assay
and identify signaling peptide agonists.
0
200
400
600
800
1000
1200
SMGS5-PnlmAB  SMdC-PnlmAB
B
e
t
a
-
G
a
l
 
A
c
t
i
v
i
t
y
 
(
M
i
l
l
e
r
 
U
n
i
t
)
CSP -
CSP +
SPA-18
0
200
400
600
800
1000
1200
0 1 53 04 56 07 59 0 1 0 5 1 2 0
Time (min)
CSP -
CSP +
SPA-18
a
b
Fig. 4. Constructed lacZ reporter strains,SMdC-PnlmABandSMGS5-PnlmAB, expresspredictedβ-gal
activity in response to CSP or agonist SPA-18. a The expression of β-gal activity in SMdC-PnlmAB is
CSP-dependent, which is in contrast to strain SMGS5-PnlmAB. b A time-course experiment indicates
that SMdC-PnlmAB expresses the highest levels of β-gal activity around 90 min after the addition of
CSP or SPA-18 and maintains such high levels of the activity for at least 2 h.
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of the Methods
to Identify Signaling
Peptide Agonists
Based on the three-dimensional structures of S. mutans wild-type
signaling peptide UA159sp (CSP) and C-terminally truncated
peptide TPC3 from mutant JH1005 defective in genetic compe-
tence, we designed and synthesized a series of truncated peptides
and peptides with amino acid substitutions (10). By functional
analysis of these peptides, we found that CSP from S. mutans dis-
played two functional domains. The C-terminal structural motif
consisting of a sequence of polar hydrophobic charged residues
is crucial for activating the signal transduction pathway, while
the core α-helical structure extending from residue 5 through
the end of the CSP is required for receptor binding. The AC50
of CSP (UA159sp) was determined to be about 25 nM (10). With
these data, we developed a rationale to design and synthesize sev-
eral new peptide agonists (Table 1). By assaying their activity in
quorum-sensing activation using the methods described here,
we found that hydrophobic residues, leucine (L) or phenylalanine
(F), could replace the hydrophilic residues at positions 9, 12, or
13 of the core α-helix of CSP without significant change of its ac-
tivity (Table 1). In contrast, peptides, F7Q, F11Q, and F15Q
that had hydrophobic phenylalanines at positions 7, 11, or 15
replaced by a hydrophilic residue, glutamine (G), failed to activate
quorum sensing (10). Inaddition,we foundthatalanine(A)at po-
sition 18 appeared to be important for the activity, since a deletion
or replacement of this residue abolished the peptide activity. The
evidence strongly suggests that the maintenance of the hydropho-
bic face of the signaling peptide is crucial for receptor recognition.
Table 1
Peptide analogs and their agonist activity in quorum sensing
Name of peptide Amino acid sequences
a AC50 (nM)
b
CSP (UA159sp) SGSLSTFFRLFNRSFTQALGK 25
TPC3 (JH1005sp) SGTLSTFFRLFNRSFTQA- - - 268
Peptide agonists
R9L SGSLSTFFLLFNRSFTQALGK 32
N12L SGSLSTFFRLFLRSFTQALGK 30
R13F SGSLSTFFRLFNFSFTQALGK 26
TPC1 SGSLSTFFRLFNRSFTQALG – 29
TPN2 - - SLSTFFRLFNRSFTQALGK 32
SPA-18 - - SLSTFFRLFNFSFTQALG - 25
aModifications of amino acid residues are in bold and underlined
bThe AC50 values were calculated from a dose–response curve using Graphpad Prism 4
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colleagues (9), who have found that the hydrophobic patch
o fC S P 1a n dC S P 2o fS. pneumoniae mainly contributes to
the receptor recognition and the specificity. Interestingly, the
hydrophobic patch in the S. pneumoniae CSP1 also consists
of three highly hydrophobic phenylalanines at positions 7, 8,
and 11 and an isoleucine at position 12. In contrast to S. pneu-
moniae, however, CSP receptor recognition in S. mutans
appears to be less specific among strains. For example, the peptides
with a truncation of N-terminal residues, such as TPN1 or TPN2,
orC-terminalresidueTPC1,also functionedas agonistswith AC50
values similar to CSP (10). These appear to be consistent with the
report of Allan et al. (28), who have found no strict correlation be-
tween the CSP genotype and the ability to induce quorum sensing
among S. mutans strains. Together, these findings suggest that the
S. mutans CSP and its variants may have less recognition specificity
of interacting with its receptor protein. Unlike S. pneumoniae that
requires two independent signaling systems, the ComCDE and
BlpRH, to regulate genetic competence and bacteriocin produc-
tion, S. mutans only uses one signaling system with more flexible
peptide–receptor interaction to regulate these phenotypes. We
speculatethatmorepeptidevariantsmaybefoundinS.mutansiso-
lates, and they likely function in the same fashion as CSP
(UA159sp) to activate quorum sensing for bacteriocin production
and genetic competence. To support this speculation, we designed
a shorter peptide agonist, SPA-18, to assay its activity. We found
thatthisshorterpeptidecouldcompletelyreplace CSP (UA159sp)
in activating quorum sensing (Fig. 4), geneticcompetence(data
not shown), and bacteriocin production (Fig. 5).
4. Conclusions
Quorum-sensing signaling systems involving the interaction be-
tween a signaling peptide and its cognate histidine kinase receptor
are widely distributed in Gram-positive bacteria. Structure–activity
analysis of signaling peptides and their analogs may provide clues
for understanding the specificity of peptide–receptor interactions
in these bacteria. In this report, we have used the S. mutans CSP
as an example to describe the methods for structure–activity analy-
sis of quorum-sensing signaling peptides by combining activity
assays with CD and NMR spectroscopy. By analyzing these
peptides, we have identified several signaling peptide agonists
that activate quorum-sensing cascade for induction of bacterio-
cin production and genetic competence in S. mutans.T h e
220 X. Tian et al.methods described herein may provide a platform for analyzing
structure–activity relationships of signaling peptides from many
other naturally transformable streptococci.
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Fig. 5. QS-controlled bacteriocin production in S. mutans strains. Only peptides CSP, SPA-18 (5), and
R13F (4) induce the same level of bacteriocins as GS5 (1).
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Protocol 1. Structural
Determination of CSPs
by CD Spectroscopy
1. Prepare 2–5 mL of a stock solution (A) to the appropriate
concentrations with non-chiral, sodium-free buffers, sol-
vents, and additives.
2. Dissolve lyophilized peptide in 1 mL of stock solution A at a
concentration of 500µM (stock solution B). For structural
determination, the stock solutions A and B must have iden-
tical concentrations of buffers, solvents, and additives.
3. Dilute stock solution B to make the peptide concentration of
100µM. Note: The quality of a CD spectrum is dependent
on the peptide concentration. Low peptide concentrations
result in poor S/N, whereas high concentrations saturate
the detector leading to artifacts.
4. Place the peptide solution in a cuvette and ensure the beam
path of the cuvette is clean. Record and average the CD spec-
traintherangeof180to250nmuntilasmoothCDspectrum
is obtained (e.g., 16 scans with a 1.0-nm increment).
5. Further dilute the peptide solution with A to 50µM, and re-
cord the CD spectra in a similar manner. Adjust the peptide
concentration and recording CD spectra so that the receiver
is not saturated, but there is enough signal for a spectrum.
6. Record the CD spectrum of solution A using identical spec-
trometer conditions.
7. Subtract the CD spectra of solution A from that obtained for
the peptide solution by using CD software.
8. Analyze the CD spectra to determine the secondary structural
features. There are several CD analysis programs and web-
based analysis interfaces such as CD analysis package
DICHROWEB (www.cryst.bbk.ac.uk/cdweb/html). Typi-
cally, the software is capable of multiple analysis algorithms.
Protocol 2. Structural
Determination of CSPs
by
1H NMR
Spectroscopy
1. Dissolve purified peptides to a concentration of >1 mM in
appropriate deuterated buffers, solvents, and additives.
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1H-
1H COSY, TOCSY, NOESY, DOSY spectra with
appropriate parameters.
3. Typically, NMR spectra are processed using sin-bell squared
apodization functions to “sharpen” the signals. Process the
spectra with the appropriate functions and phase corrections
to produce a defined spectrum.
4. Identifyasmanyindividualaminoacidsaspossiblebycorrelat-
ing protons though bonds using COSY and TOCSY spectra.
5. Determine sequence-specific assignments by connecting H
N
i
to H
α
i−1 and/or H
N
i to H
N
i±1 protons with the NOESY
spectra. Determine longer range, non-sequential
1H-
1H cor-
relations from NOESY spectra.
6. Once a number of sequence specific residues have been
assigned, integrate the appropriate NOESY cross-peaks and
estimate the corresponding distance.
7. If possible, determine the
3JH
N
H
α coupling values from the
COSY spectra. It may be necessary to fit the line shape
to determine an accurate coupling value. With the
3JH
N
H
α
coupling values, estimate the dihedral angles (if
3JH
N
H
α cou-
pling value is G6.0 Hz, α-helix;
3JH
N
H
α values between 6.0
and 8.0 Hz, random coil; and
3JH
N
H
α values >8.0 Hz, β-sheet
structures).
8. Using a simulated annealing molecular dynamics program,
determine a preliminary family of non-violating structures
from determined distances and dihedral angles.
9. Based on the preliminary structure, examine the NOESY
spectrum and assign any ambiguous peaks. Then, recalculate
structures in an iterative fashion.
Protocol 3. Signaling
Peptide-Dependent
Competence Assay
1. Inoculate a single colony of SMdC mutant into 2 mL
broth of Todd–Hewitt yeast extract (THYE) (BBL®; Becton
Dickinson, MD, USA) supplemented with 500µg/mL of
spectinomycin. The culture is incubated at 37°C overnight.
2. Transfertheovernightcultureinto2mLofpre-warmed,fresh
THYEbrothin1:20dilution.Eachcultureisincubatedfor2–
3 h to reach to the early mid-log phase (OD600≈0.2–0.3).
3. The culture is divided into two. One is added with a synthet-
ic peptide at a final concentration of 50 nM, while another
(negative control) is added with an equal volume of distilled
water.
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with a transforming DNA (plasmid pVA-gtfA) at the final
concentration of 1µg/mL. The cultures are incubated at
37°C for additional 2 h.
5. A 100-µL cell suspension from each culture is spread on a
THYE agar plate plus erythromycin (10µg/mL) after gentle
vortexing.
6. An aliquot of the cell suspension is taken, diluted, and inoc-
ulated on THYE agar plates with no antibiotic to determine
total viable cell counts.
7. All the plates are incubated at 37°C for 2 days before assess-
ment of transformation frequency, which is expressed as per-
centages of transformants (erythromycin-resistant colonies)
against total recipient cells per millimeter cell suspension.
8. An aliquot of the cell suspension prior to addition of the
transforming DNA is also taken and inoculated on THYE
plates supplemented with the same antibiotic to determine
spontaneous mutation.
Protocol 4. lacZ
Reporter Assay
for Signaling
Peptide–Receptor
Activation
1. Inoculate a single colony of each of the constructed lacZ
transcriptional reporter strains into 2 mL THYE broth for
overnight culture.
2. Transfer the overnight culture into 40 mL of pre-warmed,
fresh THYE broth in 1:20 dilution. Each culture is incubated
for 2–3 h to reach the early mid-log phase (OD600≈0.2–
0.3).
3. The culture is then divided into two. One is added with a
synthetic peptide at a final concentration of 50 nM, while an-
other (negative control) is added with an equal volume of
distilled water.
4. Aliquots of samples are taken from each culture at time
points of T0, T15, T30, T60, and T120 following the addition
of a test peptide.
5. The cell suspensions are immediately centrifuged at
10,000×g at 4°C for 10 min and the pellet is re-suspended
into chilled 50 mM Tris–HCl buffer (pH7.5) containing
0.27% (v/v) β-mercaptoethanol in a total volume of 1 mL
in a Fastprep tube.
6. Cells are permeabilized by a Fastprep instrument at a setting
of 6.0 for 30 s after addition of 50µL chloroform and 20µL
224 X. Tian et al.of 0.1% sodium dodecyl sulfate (SDS). The samples are im-
mediately centrifuged at 10,000×g at 4°C for 5 min.
7. An aliquot (100µL) of the supernatant from each sample is
added in triplicate onto a 96-well microtiter plate. Then,
50µL of O-nitrophenyl-D-galactopyranoside is added into
each well at a final concentration of 80µM.
8. The reactions are incubated for 1 h, stopped by adding 50µL
of 1 M Na2CO3 into each well, and then quantified by a
multi-detection micro-plate reader (Synergy) at 420 nm.
The reading results are saved for calculation of specific β-
gal activity.
9. An aliquot (100µL) of the supernatants is also transferred in-
to a microtiter plate for determination of the concentration
of proteins using Bio-Rad protein assay (Bio-Rad).
10. Specific β-gal activity of each sample is calculated from trip-
licate samples from two independent experiments and the
data are then normalized against negative or background
controls. Specific β-gal activity is expressed as Miller units
(A420 per min
−1 mL
−1 mg
−1 protein).
11. The data from specific β-gal activity are then plotted as per-
centages of maximal activation versus log peptide concentra-
tions. The half maximal activation concentration (AC50)i s
determined from Sigmoidal dose–response curves using
Prism 4 (Graphpad).
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